KONINKLIJKE PHILIPS N.V. earnings per share and revenue
On Nov 04, 2025, PHG reported earnings of 0.36 USD per share (EPS) for Q3 25, beating the estimate of 0.31 USD, resulting in a 14.10% surprise. Revenue reached 4.30 billion, compared to an expected 4.41 billion, with a -2.40% difference. The market reacted with a +2.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.48 USD, with revenue projected to reach 5.12 billion USD, implying an increase of 33.33% EPS, and increase of 18.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
FAQ
What were KONINKLIJKE PHILIPS N.V.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, KONINKLIJKE PHILIPS N.V. reported EPS of $0.36, beating estimates by 14.1%, and revenue of $4.30B, -2.4% below expectations.
How did the market react to KONINKLIJKE PHILIPS N.V.'s Q3 2025 earnings?
The stock price moved up 2.98%, changed from $27.21 before the earnings release to $28.02 the day after.
When is KONINKLIJKE PHILIPS N.V. expected to report next?
The next earning report is scheduled for Feb 10, 2026.
What are the forecasts for KONINKLIJKE PHILIPS N.V.'s next earnings report?
Based on 8
analysts, KONINKLIJKE PHILIPS N.V. is expected to report EPS of $0.48 and revenue of $5.12B for Q4 2025.